Monday, August 27, 2018

Aspirin may not work in avoiding first heart attack

Like many of us older folks who have been told to take a low dose aspirin everyday, this new study is disappointing for sure.  I will ask my doctor today if I should continue or not.

From the Globe

Taking a low-dose aspirin every day has long been known to cut the chances of another heart attack, stroke, or other heart problem in people who already have had one, but the risks don’t outweigh the benefits for most other folks, major new research has found.
Although it’s been used for more than a century, aspirin’s value in many situations is still unclear. The latest studies are some of the largest and longest to test this pennies-a-day blood thinner in people who don’t yet have heart disease or a blood vessel-related problem.
One found that aspirin did not help prevent first strokes or heart attacks in people at moderate risk for one because they had several health threats such as smoking, high blood pressure, or high cholesterol.

Advertisement
Another tested aspirin in people with diabetes, who are more likely to develop or die from heart problems, and found that the modest benefit it gave was offset by a greater risk of serious bleeding.
Aspirin did not help prevent cancer, as had been hoped.
And fish oil supplements, also tested in the study of people with diabetes, failed to help.
‘‘There’s been a lot of uncertainty among doctors around the world about prescribing aspirin’’ beyond those for whom it’s now recommended, said one study leader, Dr. Jane Armitage of the University of Oxford in England. ‘‘If you’re healthy, it’s probably not worth taking it.’’
The research was discussed Sunday at the European Society of Cardiology meeting in Munich. The aspirin studies used 100 milligrams a day, more than the 81-milligram pills sold in the United States but still considered low dose. Adult strength is 325 milligrams.

2 Comments:

At August 27, 2018 at 2:11 PM , Anonymous Anonymous said...

Guess sales of Bayer Asprin will be declining

 
At August 27, 2018 at 2:25 PM , Blogger jim pillsbury said...

I guess... and Bayer even paid for the study. I'll bet they never thought the outcome would be this.

 

Post a Comment

Subscribe to Post Comments [Atom]

<< Home